Navigation Links
Newer Blood Pressure Drugs Decrease Risk Of Diabetes

Patients taking newer blood pressure drugs have a decreased risk of developing diabetes, according to an analysis of the biggest clinical trial in Europe. The study found that// only 8 percent of the people on newer medicines developed diabetes as against 11.4 percent of those on older drugs.

The study involved 19,000 people. The study compared drugs like Norvasc and Coversyl with a beta-blocker and a diuretic. Norvasc is amlodipine, while Coversyl is perindopril. Professor Peter Sever of Imperial College in London, co-chairman of the study, said the findings underlined the fact that beta-blockers were no longer effecting in treating blood pressure.
RAS
'"/>




Page: 1

Related medicine news :

1. The Efficacy Of Newer Stents Questioned
2. Newer Generation Sleeping Pills Lack Superior Performance
3. Autoimmune Diseases – Newer Preventive Measure
4. Need for Newer AIDS Drugs In China
5. Newer Antidepressants May Trigger Violent Behavior
6. Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ
7. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
8. Cellulose Nanocrystal Research Paves the Way for Newer Vaccines, Computer Inks
9. Recommendations for Treatment of Blood Pressue
10. Blood Cells Capable of Regenerating Liver
11. Blood clots likely in long travel
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... the first time issued Global Air Quality Guidelin...ollution that kills 2 million// people each year w...ntries. The WHO appealed to governments to enhanc...nt issued by the WHO's regional office in Manila r...
...s to unraveling the mystery of the disease best kn...an Lou Gehrig nearly 70 years ago//. According to ...ania a team of researchers has identified the misf...g's disease or amyotrophic lateral sclerosis (ALS)...
...are going full steam to counter skin diseases tha...ent the spread of tinea(fungal infections),scabies... among infants living in the ,far flung interior a...timely and effective treatment for the same. Pov...
...er in Bihar with the detection of new cases in tho... immunisation drive this year//. Eight districts o...r the drive.Two new polio cases were detected in J...al and Nawada districts. Patna district has also f...
Other Medicine News:Health News:Clues to the Mystery of Lou Gehrig's Disease 2
(Date:10/10/2008)... SWARTZ CREEK, Mich., Oct. 10 /- D...va Neuroscience has selected Diplomat,Specialty Ph...e in a large,scale, national Therapy Optimization ... of the two year TOP MS study, is to examine the b... program on compliance, adherence and,patient outc...
(Date:10/10/2008)... PLEASANTON, Calif., Oct. 10 /- Tr...as been authorized to affix the CE (Conformite,Eur...ntares(TM) Coronary,Stent System, a unique main ve... near coronary bifurcations., Representing the ne...(TM) system has potential use in a quarter of the ...
(Date:10/9/2008)... Top Line Clinical Results Expected in November...ll/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announced ...ing,for the third of its three pivotal trials to e... of 12-hour extended-release (ER) ibuprofen for,th...ts to report top-line,results from this pivotal tr...
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmetics...RNewswire/ -- MatTek Corp. today announced,that re...i-laboratory,"catch-up" validation study on MatTek...The test results demonstrated the required sensiti... a validated alternative to animal,testing for det...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Muscular Dystrophy Treatment Shows Promise 6450 1Muscular Dystrophy Treatment Shows Promise 6450 2Muscular Dystrophy Treatment Shows Promise 6450 3Granger wins Schmidt Nielsen Mentor Scientist Award 1243 1Granger wins Schmidt Nielsen Mentor Scientist Award 1243 2USP announces 11 new proposed monographs for dietary supplements 6444 1USP announces 11 new proposed monographs for dietary supplements 6444 2Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 1Medical Services Gets Significant Interest in Its Dual VScan Test Kit 6440 2
...cer drug developer Antisoma plc,(LSE: ASM, US OTC:... trial of ASA404 in recurrent, platinum-sensitive ...ving ASA404 plus chemotherapy,(n=37) with patients...dings are as follows: , * There was no advantage i...arm compared with the control arm * One-year survi...
...RNewswire-FirstCall/ -- ImClone,Systems Incorporat...d results from an open-label Phase III study of ER... in the first-line,treatment for metastatic non-sm...et its primary endpoint of progression-free,surviv...eview,committee (IRRC). However, key secondary end...
Other Medicine Technology:Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
STA Compact is a fully automated random access coagulation analyser for clotting, photometric and immunological, latex based .coagulation tests.The medium-throughput analyser offers continous loading
Medicine Products: